Recommendations for the management of yttrium-90 radioembolization in the treatment of patients with colorectal cancer liver metastases: a multidisciplinary review
E González-Flores, N Zambudio… - Clinical and …, 2024 - Springer
Purpose Strategies for the treatment of liver metastases from colon cancer (lmCRC) are
constantly evolving. Radioembolization with yttrium 90 (Y-90 TARE) has made significant …
constantly evolving. Radioembolization with yttrium 90 (Y-90 TARE) has made significant …
Advancements in the Management of Synchronous Colorectal Liver Metastases: A Comprehensive Review of Surgical, Systemic, and Local Treatment Modalities
BB Karaoğlan, DK Öz, MS Araz, C Akyol… - Current Oncology …, 2024 - Springer
Abstract Purpose of Review This review addresses the current landscape of colorectal
cancer (CRC) with a focus on liver metastases, the third most common cancer globally. It …
cancer (CRC) with a focus on liver metastases, the third most common cancer globally. It …
Amentoflavone induces caspase‐dependent/− independent apoptosis and dysregulates cyclin‐dependent kinase‐mediated cell cycle in colorectal cancer in vitro and …
CH Lin, KH Lin, HJ Ku, KC Lee, SS Lin… - Environmental …, 2023 - Wiley Online Library
Colorectal cancer (CRC) is recognized as the third most common malignancy and the
second most deadly in highly developed countries. Although the treatment of CRC has …
second most deadly in highly developed countries. Although the treatment of CRC has …
Contrast‐Enhanced Ultrasound With SonoVue and Sonazoid for the Diagnosis of Colorectal Liver Metastasis After Chemotherapy
L Sun, S Yin, B Xing, Z Li, Z Fan… - Journal of Ultrasound in …, 2023 - Wiley Online Library
Purpose To compare the diagnostic efficacy of SonoVue and Sonazoid contrast‐enhanced
ultrasound (CEUS) in correctly detecting and characterizing colorectal liver metastasis …
ultrasound (CEUS) in correctly detecting and characterizing colorectal liver metastasis …
Neoadjuvant chemotherapy followed by radiofrequency ablation may be a new treatment modality for colorectal liver metastasis: a propensity score matching …
Y Chen, Y Huang, L Xu, J Wu, F Han, H Jiang, P Zheng… - Cancers, 2022 - mdpi.com
Simple Summary Whether neoadjuvant chemotherapy followed by radiofrequency ablation,
a new therapeutic modality, may achieve a similar prognosis to neoadjuvant chemotherapy …
a new therapeutic modality, may achieve a similar prognosis to neoadjuvant chemotherapy …
High‐intensity focused ultrasound ablation combined with systemic therapy for unresectable colorectal cancer liver metastasis: A propensity score‐matched analysis
F Tang, Q Zhong, T Ni, Y Xue, J Wu, R Deng… - Cancer …, 2023 - Wiley Online Library
Objective Unresectable colorectal cancer liver metastasis (CRLM) remains a challenging
obstacle that often prevents curative treatment. In this study, we retrospectively analyzed the …
obstacle that often prevents curative treatment. In this study, we retrospectively analyzed the …
Microwave ablation combined with lipiodol-microsphere mixed or conventional transarterial chemoembolization for the treatment of colorectal liver metastases: a …
Q Shi, F Wang, N Du, Y Zhou, X Zhou, J Ma… - Clinics and Research in …, 2022 - Elsevier
Purpose To investigate the clinical outcomes of microwave ablation (MWA) combined with
lipiodol-microsphere mixed transarterial chemoembolization (mTACE) or conventional …
lipiodol-microsphere mixed transarterial chemoembolization (mTACE) or conventional …
In Vivo Thermal Ablation of Deep Intrahepatic Targets Using a Super-Convergent MRgHIFU Applicator and a Pseudo-Tumor Model
O Lorton, PC Guillemin, A Peloso, Y M'Rad, LA Crowe… - Cancers, 2023 - mdpi.com
Simple Summary Magnetic-resonance-guided high-intensity focused ultrasound (MRgHIFU)
is a promising technology for ablation of liver tumors not eligible for surgery. This study …
is a promising technology for ablation of liver tumors not eligible for surgery. This study …
Interventional radiological therapies in colorectal hepatic metastases
SSR Vulasala, PD Sutphin, S Kethu… - Frontiers in …, 2023 - frontiersin.org
Colorectal malignancy is the third most common cancer and one of the prevalent causes of
death globally. Around 20-25% of patients present with metastases at the time of diagnosis …
death globally. Around 20-25% of patients present with metastases at the time of diagnosis …
Hyperforin suppresses oncogenic kinases and induces apoptosis in colorectal cancer cells
LC Hsu, CY Kuo, FT Hsu, HF Chang, JJ Ou - in vivo, 2023 - iv.iiarjournals.org
Abstract Background/Aim: Signal transducer and activator of transcription 3 (STAT3), Janus
Kinase 1 (JAK1), extracellular signal-regulated kinase (ERK), and protein kinase B (AKT) …
Kinase 1 (JAK1), extracellular signal-regulated kinase (ERK), and protein kinase B (AKT) …